Literature DB >> 9702898

MR-guided biopsy using a T2-weighted single-shot zoom imaging sequence (Local Look technique).

A Buecker1, G Adam, J M Neuerburg, A Glowinski, J J van Vaals, R W Guenther.   

Abstract

The purpose of this study was to demonstrate the utility of a T2-weighted single shot turbo spin-echo technique--the so-called "Local Look" (LoLo) and more recently renamed "Zoom Imaging" technique--for MR-guided percutaneous interventions. We performed 28 procedures on 22 patients using a 1.5-T system for MR guidance. All procedures were controlled with the LoLo technique, which acquires T2-weighted images in 600 msec. This is achieved by using a small field of view (250 x 125 mm) along with a maximum echo train length, the so-called "single shot method." To prevent backfolding artifacts, the 90 degrees and 180 degrees pulses were oriented orthogonally to each other. Because signal is created only in the region in which the pulses overlap, no backfolding can occur from outside this area. Half of the biopsies were additionally monitored using a fast gradient-echo sequence, which was compared with the LoLo technique. All of the procedures were technically successful, and there were no procedural complications. The LoLo technique produced images that had good contrast between the lesion and the needle artifact, and the artifact size was smaller than that produced by the gradient-echo technique. Subjective judgment of the ability to accurately delineate the needle tip indicated that the LoLo technique was either superior to (73%) or equal to (27%) the gradient-echo sequence in all cases. The LoLo technique is an accurate and effective method for MR guidance of percutaneous procedures, because it shows good lesion contrast and small needle artifacts. The additional use of a gradient-echo sequence during the procedure planning stage is advisable in more difficult cases, particularly when adjacent blood vessels are a concern. Monitoring of the needle tip is best performed with the LoLo technique.

Entities:  

Mesh:

Year:  1998        PMID: 9702898     DOI: 10.1002/jmri.1880080426

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Cost comparison analysis of low-field (0.23 T) MRI- and CT-guided bone biopsies.

Authors:  J Alanen; L Keski-Nisula; R Blanco-Sequeiros; O Tervonen
Journal:  Eur Radiol       Date:  2003-06-25       Impact factor: 5.315

2.  Evaluation of local look diffusion tensor imaging for magnetic resonance tractography of the periprostatic neurovascular bundle.

Authors:  Wataru Jomoto; Masao Tanooka; Tsukasa Wakayama; Takahiro Minamoto; Toru Suzuki; Reiichi Ishikura; Shingo Yamamoto; Noriko Kotoura
Journal:  Radiol Phys Technol       Date:  2018-08-04

3.  Towards clinical assessment of velopharyngeal closure using MRI: evaluation of real-time MRI sequences at 1.5 and 3 T.

Authors:  A D Scott; R Boubertakh; M J Birch; M E Miquel
Journal:  Br J Radiol       Date:  2012-07-17       Impact factor: 3.039

4.  MRI of blood flow of the human retina.

Authors:  Qi Peng; Yi Zhang; Oscar San Emeterio Nateras; Matthias J P van Osch; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2011-02-24       Impact factor: 4.668

5.  Targeted single-shot methods for diffusion-weighted imaging in the kidneys.

Authors:  Ning Jin; Jie Deng; Longjiang Zhang; Zhuoli Zhang; Guangming Lu; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

6.  Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors.

Authors:  Jie Deng; Sumeet Virmani; Guang-Yu Yang; Richard Tang; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

7.  Multishot targeted PROPELLER magnetic resonance imaging: description of the technique and initial applications.

Authors:  Jie Deng; Andrew C Larson
Journal:  Invest Radiol       Date:  2009-08       Impact factor: 6.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.